131 related articles for article (PubMed ID: 6316483)
1. Serum testosterone, LH, and FSH in patients with testicular cancer before and after radio- and chemotherapy.
Berthelsen JG; Engelholm SA; von der Maase H; Rørth M
Scand J Urol Nephrol; 1983; 17(3):287-90. PubMed ID: 6316483
[TBL] [Abstract][Full Text] [Related]
2. Testosterone, LH and FSH in patients with treated testicular carcinomas.
Dunzendorfer U; Weber W
Horm Metab Res; 1978 Mar; 10(2):156-7. PubMed ID: 649040
[TBL] [Abstract][Full Text] [Related]
3. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
[TBL] [Abstract][Full Text] [Related]
4. [Changes in serum hormones and the spermiogram in patients with malignant testicular tumors following radiation and cytostatic drug therapy].
Barth V; Hums R
Z Urol Nephrol; 1990 Jun; 83(6):291-5. PubMed ID: 2171246
[TBL] [Abstract][Full Text] [Related]
5. Serum hormone levels in patients with malignant testicular germ cell tumours without clinical and/or radiological signs of tumour.
Fosså SD; Klepp O; Aakvaag A
Br J Urol; 1980 Apr; 52(2):151-7. PubMed ID: 6775725
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function in men with testis cancer.
Berthelsen JG; Skakkebaek NE
Fertil Steril; 1983 Jan; 39(1):68-75. PubMed ID: 6293886
[TBL] [Abstract][Full Text] [Related]
8. Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer.
Berthelsen JG
Fertil Steril; 1984 Feb; 41(2):281-6. PubMed ID: 6199233
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of gonadotropins and testosterone during the course of treatment for a case with gonadotropin secteting testicular tumor (author's transl)].
Fukutani K; Isurugi K; Kinoshita K
Nihon Hinyokika Gakkai Zasshi; 1974 Jul; 65(7):454-60. PubMed ID: 4476889
[No Abstract] [Full Text] [Related]
10. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
11. Gonadal dysfunction in patients treated for metastatic germ-cell tumors.
Leitner SP; Bosl GJ; Bajorunas D
J Clin Oncol; 1986 Oct; 4(10):1500-5. PubMed ID: 3020183
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
13. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
[TBL] [Abstract][Full Text] [Related]
14. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
15. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
17. [Dependence of serum hormones (T, FSH, LH) on morphometric testicular findings after chemo- and radiotherapy in patients with malignant testicular tumors].
Barth V; Schönfelder M
Zentralbl Allg Pathol; 1990; 136(5):439-42. PubMed ID: 2122615
[TBL] [Abstract][Full Text] [Related]
18. Associations of preorchiectomy hormone levels to testicular germ cell tumor pathology, clinical stage, and size.
Pineault KG; Cheaib JG; Herati AS; Pierorazio PM
Asian J Androl; 2021; 23(2):224-226. PubMed ID: 32567579
[No Abstract] [Full Text] [Related]
19. [Sperm, LH FSH, testosterone evaluation in patients with testicular cancer. Preliminary study].
Demkow T; Faundez R; Madej G
Ginekol Pol; 1998 Jun; 69(6):405-9. PubMed ID: 9695352
[TBL] [Abstract][Full Text] [Related]
20. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
